Bo Chen
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 13
- RNA modifications and cancer 7
-
- MicroRNA in disease regulation 23
- Breast Cancer Treatment Studies 16
- Cancer-related molecular mechanisms research 13
- Co-authors
- Hailin Tang (8 shared papers)Xiaoming Xie (6 shared papers)Satu Kuokkanen (1 shared paper)Jeffrey W. Pollard (1 shared paper)Nanette Santoro (1 shared paper)Lumie Benard (1 shared paper)Laureen S. Ojalvo (1 shared paper)Weidong Wei (4 shared papers)
- Journals
- Frontiers in Oncology (11 papers)PLoS ONE (6 papers)Scientific Reports (5 papers)Oncotarget (5 papers)Fish & Shellfish Immunology (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bo Chen
178 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 135
- Cancer Research 967
- Molecular Biology 1.4k
- Complementary and alternative medicine 130
- Reproductive Medicine 129
- Immunology 331
Countries citing papers authored by Bo Chen
This map shows the geographic impact of Bo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Chen more than expected).
Fields of papers citing papers by Bo Chen
This network shows the impact of papers produced by Bo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Chen. The network helps show where Bo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 236 | |
| 2 | 2021 | 137 | |
| 3 | 2016 | 115 | |
| 4 | 2010 | 112 | |
| 5 | 2014 | 101 | |
| 6 | 2014 | 93 | |
| 7 | 2011 | 91 | |
| 8 | 2014 | 84 | |
| 9 | 2018 | 73 | |
| 10 | 2022 | 71 | |
| 11 | 2017 | 70 | |
| 12 | 2008 | 67 | |
| 13 | 2014 | 67 | |
| 14 | 2009 | 63 | |
| 15 | 2013 | 61 | |
| 16 | 2017 | 58 | |
| 17 | 2017 | 54 | |
| 18 | 2011 | 49 | |
| 19 | 2013 | 47 | |
| 20 | 2013 | 41 |
About Bo Chen
Bo Chen is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 195 papers that have together received 3.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Breast Cancer Treatment Studies (16 papers), Cancer-related molecular mechanisms research (13 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (7 papers), Acupuncture Treatment Research Studies (6 papers) and Central Venous Catheters and Hemodialysis (6 papers). The work is most often cited by research in Cancer Research (967 citations), Molecular Biology (1.4k citations), Complementary and alternative medicine (130 citations), Reproductive Medicine (129 citations) and Immunology (331 citations). Bo Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hailin Tang, Xiaoming Xie, Satu Kuokkanen, Jeffrey W. Pollard, Nanette Santoro, Lumie Benard, Laureen S. Ojalvo, Weidong Wei, Cailu Song and Xiaoping Liu. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Scientific Reports, Oncotarget and Fish & Shellfish Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.